UNSPSC 51313113: Chlorcyclizine dihydrochloride

This classification denotes a histamine-1 receptor antagonist with the molecular formula C18H21ClN2.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 61Y56T95YL, chemically known as piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-methyl-, hydrochloride (1:2), but more generally known as chlorcyclizine dihydrochloride, which bears US NIH Compound Identifier 101605. European Medicines Agency schedules chlorcyclizine dihydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06178MIG.

Most nations, for tariff purposes, schedule chlorcyclizine dihydrochloride under HS 29335995. SMILES: CN1CCN(CC1)C(C2CCCCC2)C3CCC(CC3)CL.CL.CL.

UNSPSC 51313113 Chlorcyclizine dihydrochloride is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The source identifies a single recent opportunity — Seminole County, Florida's IFB60459723LAS for naloxone and drug deactivation systems — which falls outside the scope of a pharmaceutical chemical compound and instead represents public health supply procurement. The code shows little relevant recent activity for its nominal product category.

Seminole County's IFB, posted June 30, 2026 with a response deadline of July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. Bidders were required to submit electronically through the county's e-Procurement Portal, include all shipping and delivery costs in their proposals, comply with drug-free workplace certification and E-Verify requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The initial contract term was two years with an option for one-year renewal, subject to a three-month probationary period during which the county could terminate with or without cause. The procurement carried potential FEMA funding and associated federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act. No explicit set-aside designations for disadvantaged enterprises were noted, and no specific budget range was disclosed.